FDA & Prescription Drugs

• Source of Fusarium Keratitis Fungus Still a Mystery

  Joe Saunders | May 07, 2006 9:58 AM | 0 CommentsOrlando, FL

  According to an article in the NY Times, a researcher hired by Bausch & Lomb has published a report indicating that the infection is not coming from the eye contact solution. The FDA and CDC have not commented directly on his findings. FDA officials declined to comment yesterday on Mr. Geiser's assessment. But the agency's Web site posted an update saying that while it continued to confirm...

• 5 More Suspected Cases of Fungal Eye Infection in Tennessee

  Joe Saunders | May 05, 2006 4:16 AM | 0 CommentsOrlando, FL

  With reports of the fusarium keratitis fungus appearing in Europe, the number of cases in Tennessee continues to mount. I haven't read a good explanation for this but the number of eye fungus infections associated with Bausch & Lomb's ReNu products is quite high in comparison with other states.

• Bausch & Lomb Fungus Enters Europe

  Joe Saunders | May 04, 2006 3:31 PM | 0 CommentsOrlando, FL

  New cases of the fusarium keratitis fungus have been confirmed in Europe. The cases represent the first time the company has acknowledged European incidents of the infection, which has struck Bausch solution users in Asia and the U.S. The outbreak has led the company to halt shipments of one of its products, ReNu with MoistureLoc, in several countries and to scrutinize a manufacturing plant in...

• Sites Set on Bausch & Lomb

  Joe Saunders | May 04, 2006 7:03 AM | 0 CommentsOrlando, FL

  As the days pass, the news continues to get worse for Bausch & Lomb. Initially, the company asked consumers to stop using one of their products, ReNu with MoistureLoc. In the intervening weeks, company execs tried to intimate that if there was a problem at all, it was restricted to the one product. Now that the CDC report comes out we know otherwise. Let's take a look a the CDC numbers: ...

• Bristol Myers Squibb to Stop Selling Tequin

  Joe Saunders | May 03, 2006 8:50 AM | 0 CommentsOrlando, FL

  In a conference call with investors, Bristol Myers Squibb has announced that it will no longer sell Tequin although it stopped short of saying that the product will be removed from store shelves. The decision comes on the heels of Public Citizen's call to ban the drug.

• Why Bausch & Lomb Withdrew ReNu from the Market

  Joe Saunders | May 03, 2006 8:47 AM | 0 CommentsOrlando, FL

  The relationship between the recent outbreak of fusarium keratitis and Bausch & Lomb's ReNu eye contact solution is becoming clearer as the CDC and the FDA continues its investigation. According to an article in Reuters, "The 57 percent share of cases preliminarily reported for the company's MoistureLoc formula is significantly and disproportionately higher than its U.S. market share of less...

• Su ReNu Abogado

  Joe Saunders | May 01, 2006 9:10 PM | 0 CommentsOrlando, FL

  Si ud. ha estado usando la solución ReNu para sus lentes de contacto y ha experimentado una herida de los ojos, posiblemente podría recibir compensación por su herida. Es muy importante que ud. consulte con un oftalmólogo inmediatamente. El doctor tiene que tomar una muestra de sus ojos para determinar si tiene el hongo fusarium keratitis. Favor de llamar a nuestra oficina para una...

• Bausch & Lomb Notified by Hong Kong Officials in Fall 2005

  Joe Saunders | April 28, 2006 10:20 AM | 0 CommentsOrlando, FL

  According to an article published in the Wall St. Journal, the maker of ReNu contact lens solution, was notified of eye infections in November 2005. The number of those infected with the fungus fusarium keratitits has now risen from 176 last week to 186 cases in 29 states. The product distributed in Singapore and Hong Kong is manufactured at the same South Carolina plant as product sold in the...

• Bausch & Lomb Lawsuit Filing Today

  Joe Saunders | April 27, 2006 9:26 AM | 0 CommentsOrlando, FL

  This afternoon I'll be filing a civil lawsuit against Bausch & Lomb, the manufacturer of ReNu contact lens solution. I'll be filing in US District Court for the Middle District of Florida on behalf of a woman who has lost nearly 80% of her vision in her left eye. Unfortunately, she is not a surgical candidate.

• FDA Experts' Conflicts of Interest

  Joe Saunders | April 26, 2006 9:19 AM | 0 CommentsOrlando, FL

  As a governmental oversight agency, it should be appalling that the FDA uses experts who have financial interests in the drugs and products about which they provide expert testimony. Yet, in a study conducted by the consumer group Public Citizen, that is exactly what is happening. How can any expert provide unbiased testimony about a product in which they've bought stock or have some financial...